Jade Biosciences, Inc.
Company Stats
- Market Cap
- $893.5M
- as of Sep 30, 2026
- Shares Outstanding
- 63.6M
- Free Float
- 71.8%
Income Statement
- Operating Income
- -$113.5M
- Net Income
- -$127.4M
- EBITDA
- -$113.5M
Cash Flow
- Free Cash Flow
- -$94.9M
- FCF Yield
- -10.6%
- Owner FCF Yield
- -12.9%
Balance Sheet
- Cash & Equivalents
- $88.4M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$94.9M | — |
| FY2023 | — | -$56.9M | — |
| FY2022 | — | -$39.3M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of November 4, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges